CN102526509B - Medicine for treating hepatomegaly - Google Patents
Medicine for treating hepatomegaly Download PDFInfo
- Publication number
- CN102526509B CN102526509B CN2012100215466A CN201210021546A CN102526509B CN 102526509 B CN102526509 B CN 102526509B CN 2012100215466 A CN2012100215466 A CN 2012100215466A CN 201210021546 A CN201210021546 A CN 201210021546A CN 102526509 B CN102526509 B CN 102526509B
- Authority
- CN
- China
- Prior art keywords
- hepatomegaly
- medicine
- treating
- tablets
- semen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention relates to a medicine for treating hepatomegaly. The medicine for treating the hepatomegaly comprises the medicinal raw materials as follows: 7g of gastrodia elata, 7g of Rhizoma Pinelliae, 7g of taro pulp, 5g of pharbitis seed, 3g of garden burnet, 3g of Astragalus mongholicus, 5g of fructus psoraleae and 5g of date kernel; and the medicine for treating the hepatomegaly also comprises the components as follows: 20 furazolidone tablets, 20 terramycin tablets, 15 compound acetylsalicylic acid tablets, 2 belladonna tablets and 5 flu-treating capsules. The medicine for treating the hepatomegaly has the advantages that the medicine for treating the hepatomegaly can treat hepatomegaly caused by various reasons, has an obvious therapeutic effect and takes effect quickly; and through combined therapy of the traditional Chinese medicine and Western medicine, the used Western medicinal raw materials are finished medicines sold in the market, with wide source, easy obtainment and low price, so that the medicine for treating the hepatomegaly is low in cost and high in cost performance.
Description
Technical field
The present invention relates to a kind of medicine for the treatment of hepatomegaly.
Background technology
Hepatomegaly is a kind of commonly encountered diseases, pathogenic factor mainly is divided into infectious hepatomegaly and non-infectious hepatomegaly, that the source of infection of infectious hepatomegaly mainly contains is viral, chlamydia, rickettsia, antibacterial, spirillum, fungus, protozoon, anthelmintic, and non-viral infects and mainly contains toxic, congestion, cholestasis, dysbolismus, liver cirrhosis, tumor and cyst etc.
Treat at present hepatomegaly, main Therapeutic Method is first to understand its pathogenesis, then suit the remedy to the case, but sometimes hepatomegaly is the omen of some disease, if can not treat in time, likely can delay treatment, and if pathogenesis misjudge, the medication that likely can lead to errors, lose the best opportunity for the treatment of, thereby cause serious consequence.
Summary of the invention
In order to solve above treatment hepatomegaly not in time, need to find the problem that the cause of disease could medication, the invention provides a kind of medicine that can effectively treat the hepatomegaly that the various causes of disease cause.
The present invention is achieved by the following measures:
A kind of medicine for the treatment of hepatomegaly, crude drug contains following composition:
Rhizoma Gastrodiae 7g, Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 7g, taro meat 7g, Semen Pharbitidis 5g, Radix Sanguisorbae 3g, Radix Astragali 3g, Fructus Psoraleae 5g, Semen Ziziphi Spinosae 5g.
Described medicine, also contain following composition:
20 of furazolidone sheets, 20 of hydroxytetracycline tablets, 15 of phenacetin+caffeine+aspirins, 2 of Semen daturae tablets, 5 of cold relief capsules.
The furazolidone sheet is the commercially available finished medicines that can buy, and a lot of enterprises productions are arranged, and specification mainly contains 10mg, 30mg or 100mg, can use in medicine of the present invention.
Hydroxytetracycline tablet is the commercially available finished medicines that can buy, and a lot of enterprises productions are arranged, and specification mainly contains 0.125g or 0.25g, can use in medicine of the present invention.
Phenacetin+caffeine+aspirin is the commercially available finished medicines that can buy, and a lot of enterprises productions are arranged, and every containing aspirin 0.22g, phenacetin 0.15g, caffeine 35mg.
In Semen daturae tablet, containing 10 milligrams of Semen daturae extractums, Semen daturae extractum is the extractum that Herba Belladonnae is processed into through ethanol extraction, and extractive technique has been also the technology of existing maturation.
The cold relief capsule component is: every containing acetaminophen 250mg, amantadine hydrochloride 100mg, artificial Calculus Bovis 10mg, caffeine 15mg, chlorphenamine maleate 2mg.
Described medicine, make pill.
Rhizoma Gastrodiae: endogenous wind stopping relieving convulsion, suppressing the hyperactive liver and subsiding YANG, dispelling wind and removing obstruction in the collateral.
Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens): the removing dampness spleen invigorating, antidiarrheal helps digestion.
Taro meat: the meat of Fructus Colocasiae Esculentae, the sweet suffering of Fructus Colocasiae Esculentae nature and flavor, flat.There is the QI invigorating kidney tonifying, the effect of removing blood stasis eliminating stagnation.
Semen Pharbitidis: the removing water retention by purgation relieving constipation, drink is washed in expectorant, and parasite killing is attacked long-pending.
Radix Sanguisorbae: cooling blood for hemostasis, heat-clearing and toxic substances removing, detumescence sore.
The Radix Astragali: invigorating QI to consolidate the body surface resistance, diuretic detumescent, expelling pus and toxin by strengthening QI, granulation promoting.
Fructus Psoraleae: be the fruit of legumes psoraleae.Reinforcing the kidney and supporting YANG; Helping inspiration to relieve asthma; Warming spleen and stopping diarrha.
Semen Ziziphi Spinosae: nourish heart, calm the nerves, arresting sweating.
Beneficial effect of the present invention: can treat the hepatomegaly that the various causes of disease cause, therapeutic effect is obvious, instant effect; Adopt therapy of combining Chinese and Western medicine, Western medicine raw material used is commercially available finished medicines, and wide material sources easily obtain, and low price, make medicine of the present invention with low cost, and cost performance is high.
The specific embodiment
For a better understanding of the present invention, below in conjunction with specific embodiment, further illustrate.
Embodiment 1:
A kind of medicine for the treatment of hepatomegaly, crude drug contains following composition:
Rhizoma Gastrodiae 7g, Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 7g, taro meat 7g, Semen Pharbitidis 5g, Radix Sanguisorbae 3g, Radix Astragali 3g, Fructus Psoraleae 5g, Semen Ziziphi Spinosae 5g.
Preparation method: each crude drug was crushed to 80 mesh sieves, adds binding agent to make 10 pills.
Embodiment 2:
A kind of medicine for the treatment of hepatomegaly, crude drug contains following composition:
Rhizoma Gastrodiae 7g, Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 7g, taro meat 7g, Semen Pharbitidis 5g, Radix Sanguisorbae 3g, Radix Astragali 3g, Fructus Psoraleae 5g, Semen Ziziphi Spinosae 5g,
20 of furazolidone sheets (10mg/sheet), 20 of hydroxytetracycline tablets (0.125g/ sheet), 15 of phenacetin+caffeine+aspirins, 2 of Semen daturae tablets, 5 of cold relief capsules.
Preparation method: each crude drug was crushed to 80 mesh sieves, adds binding agent to make 10 pills.
Embodiment 3:
A kind of medicine for the treatment of hepatomegaly, crude drug contains following composition:
Rhizoma Gastrodiae 7g, Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 7g, taro meat 7g, Semen Pharbitidis 5g, Radix Sanguisorbae 3g, Radix Astragali 3g, Fructus Psoraleae 5g, Semen Ziziphi Spinosae 5g,
20 of furazolidone sheets (30mg/sheet), 20 of hydroxytetracycline tablets (0.125g/ sheet), 15 of phenacetin+caffeine+aspirins, 2 of Semen daturae tablets, 5 of cold relief capsules.
Preparation method: each crude drug was crushed to 80 mesh sieves, adds binding agent to make 10 pills.
Embodiment 4:
A kind of medicine for the treatment of hepatomegaly, crude drug contains following composition:
Rhizoma Gastrodiae 7g, Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 7g, taro meat 7g, Semen Pharbitidis 5g, Radix Sanguisorbae 3g, Radix Astragali 3g, Fructus Psoraleae 5g, Semen Ziziphi Spinosae 5g,
20 of furazolidone sheets (100mg/sheet), 20 of hydroxytetracycline tablets (0.25g/ sheet), 15 of phenacetin+caffeine+aspirins, 2 of Semen daturae tablets, 5 of cold relief capsules.
Preparation method: each crude drug was crushed to 80 mesh sieves, adds binding agent to make 10 pills.
The clinical effectiveness experiment:
Gathering patient examination has case 36 examples of hepatomegaly symptom, and wherein 16 examples are because hepatitis causes, 5 examples cause by liver abscess, and 11 examples cause by fatty liver, and 4 examples are caused by liver cirrhosis.36 routine patient clinical symptoms all reach the clinical appraisal standard of hepatomegaly.
36 routine patients are divided into to 4 groups, and the medicine that uses respectively above-described embodiment 1-4 to prepare is treated,
Wherein contain the hepatomegaly patient that 4 examples are caused by hepatitis, the hepatomegaly that 2 examples are caused by liver abscess, the hepatomegaly that 2 examples are caused by fatty liver, the hepatomegaly that 1 example is caused by liver cirrhosis in 1 group;
Contain the hepatomegaly patient that 4 examples are caused by hepatitis in 2 groups, the hepatomegaly that 1 example is caused by liver abscess, the hepatomegaly that 3 examples are caused by fatty liver, the hepatomegaly that 1 example is caused by liver cirrhosis;
Contain the hepatomegaly patient that 4 examples are caused by hepatitis in 3 groups, the hepatomegaly that 1 example is caused by liver abscess, the hepatomegaly that 3 examples are caused by fatty liver, the hepatomegaly that 1 example is caused by liver cirrhosis;
Contain the hepatomegaly patient that 4 examples are caused by hepatitis in 4 groups, the hepatomegaly that 1 example is caused by liver abscess, the hepatomegaly that 3 examples are caused by fatty liver, the hepatomegaly that 1 example is caused by liver cirrhosis.
1 group of patient as a control group, only according to the Therapeutic Method for the treatment of disease itself, treated, not specially for the hepatomegaly drug administration, 2,3,4 groups of patients, except being treated with 1 group of the same Therapeutic Method according to treatment disease itself, take respectively the bolus of drug of embodiment 1,2,4 preparations, and administrated method is to take every day twice, each half, within 7 days, be a course for the treatment of, take altogether two courses for the treatment of, observe the curative effect.
The hepatomegaly curative effect determinate standard:
Recovery from illness: hepatomegaly transference cure;
Effectively: the hepatomegaly symptom alleviates to some extent, but not recovery from illness;
Invalid: the hepatomegaly symptom is without alleviating.
4 groups of patient treatment situation statistical tables see the following form.
As can be seen from the above table, medicine of the present invention has good curative effect aspect treatment hepatomegaly, and the medicine of embodiment 2 and 4 preparations is better than the therapeutic effect of the medicine of embodiment 1 preparation.
Typical Case
1, Wang, the female, 61 years old, under the costal margin of patient right side, the liver lower edge was not touched, tenderness, the high heat of shiver with cold, upper right abdomen pain, diagnostic result is hepatitis B, and with hepatomegaly.When using the treatment hepatitis B medicine, take the medicine for the treatment of hepatomegaly of the present invention, after taking a course for the treatment of, tenderness is clearly better, and after two courses for the treatment of, checks and finds the hepatomegaly transference cure, inspired greatly the confidence of Rehabilitation, the positive partner treatment of rear patient, the state of an illness is controlled, and leaves hospital smoothly.
2, grandson, the man, 29 years old, the violent and pain of persistence in hepatic region, changed or cough aggravates with position, is liver abscess after diagnosing, and the hepatomegaly symptom is very serious.The patient, in the medicine that uses the treatment liver abscess, takes medicine of the present invention, and after taking a course for the treatment of, the hepatomegaly symptom obviously alleviates, and liver abscess also obviously alleviates.Take medicine after two courses for the treatment of, liver abscess is fully recovered, the hepatomegaly recovery from illness.
Claims (6)
1. a medicine for the treatment of hepatomegaly, is characterized in that the crude drug weight proportion is as follows: Rhizoma Gastrodiae 7g, Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 7g, Fructus Colocasiae Esculentae meat 7g, Semen Pharbitidis 5g, Radix Sanguisorbae 3g, Radix Astragali 3g, Fructus Psoraleae 5g, Semen Ziziphi Spinosae 5g.
2. a medicine for the treatment of hepatomegaly, is characterized in that the crude drug weight proportion is as follows: Rhizoma Gastrodiae 7g, Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 7g, Fructus Colocasiae Esculentae meat 7g, Semen Pharbitidis 5g, Radix Sanguisorbae 3g, Radix Astragali 3g, Fructus Psoraleae 5g, Semen Ziziphi Spinosae 5g, 20 of furazolidone sheets, 20 of hydroxytetracycline tablets, 15 of phenacetin+caffeine+aspirins, 2 of Semen daturae tablets, 5 of cold relief capsules;
DescribedContain 10 milligrams of Semen daturae extractums in Semen daturae tablet;
DescribedThe cold relief capsule component is: every containing acetaminophen 250mg, amantadine hydrochloride 100mg, artificial Calculus Bovis 10mg, caffeine 15mg, chlorphenamine maleate 2mg.
3. medicine according to claim 2, is characterized in that the specification that the furazolidone sheet is 10mg, 30mg or 100mg.
4. medicine according to claim 2, is characterized in that the hydroxytetracycline tablet specification is 0.125g or 0.25g.
5. medicine according to claim 2, is characterized in that phenacetin+caffeine+aspirin, and every containing aspirin 0.22g, phenacetin 0.15g, caffeine 35mg.
6. medicine according to claim 1 and 2, is characterized in that making pill.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012100215466A CN102526509B (en) | 2012-01-31 | 2012-01-31 | Medicine for treating hepatomegaly |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012100215466A CN102526509B (en) | 2012-01-31 | 2012-01-31 | Medicine for treating hepatomegaly |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102526509A CN102526509A (en) | 2012-07-04 |
| CN102526509B true CN102526509B (en) | 2013-12-04 |
Family
ID=46335329
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012100215466A Expired - Fee Related CN102526509B (en) | 2012-01-31 | 2012-01-31 | Medicine for treating hepatomegaly |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102526509B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103751547B (en) * | 2014-01-21 | 2016-02-24 | 四川绿禾药业有限公司 | Chinese medicine composition of a kind of blood fat reducing and preparation method thereof |
| CN106177760A (en) * | 2016-07-30 | 2016-12-07 | 陈国礼 | A kind of medicine treating hepatomegaly and preparation method |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1216703A (en) * | 1997-12-23 | 1999-05-19 | 李伟 | Medicine for treating enterogastric disease |
| CN1443557A (en) * | 2003-02-10 | 2003-09-24 | 裴艳锋 | Yigante capsule for curing hepatitis B |
| CN1943779A (en) * | 2006-11-07 | 2007-04-11 | 闫敬武 | The processing method of bupleurum root preparation and its application |
| CN101204532A (en) * | 2007-12-19 | 2008-06-25 | 孙义岭 | Medicine for prostate disease and preparation method thereof |
| CN101301364A (en) * | 2008-06-19 | 2008-11-12 | 池晓玲 | Externally used Chinese medicine for treating cirrhosis ascites and preparation thereof |
| CN102114211A (en) * | 2010-11-26 | 2011-07-06 | 易国松 | Chinese herbal medicine for treating hepatopathy |
-
2012
- 2012-01-31 CN CN2012100215466A patent/CN102526509B/en not_active Expired - Fee Related
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1216703A (en) * | 1997-12-23 | 1999-05-19 | 李伟 | Medicine for treating enterogastric disease |
| CN1443557A (en) * | 2003-02-10 | 2003-09-24 | 裴艳锋 | Yigante capsule for curing hepatitis B |
| CN1943779A (en) * | 2006-11-07 | 2007-04-11 | 闫敬武 | The processing method of bupleurum root preparation and its application |
| CN101204532A (en) * | 2007-12-19 | 2008-06-25 | 孙义岭 | Medicine for prostate disease and preparation method thereof |
| CN101301364A (en) * | 2008-06-19 | 2008-11-12 | 池晓玲 | Externally used Chinese medicine for treating cirrhosis ascites and preparation thereof |
| CN102114211A (en) * | 2010-11-26 | 2011-07-06 | 易国松 | Chinese herbal medicine for treating hepatopathy |
Non-Patent Citations (5)
| Title |
|---|
| 《中医治疗水肿药物配伍规律的研究》;战志华等;《承德医学院学报》;20050330;第22卷(第1期);第34-38页 * |
| 《肝肿大》;尚清秀等;《社区医学杂志》;20071220;第5卷(第24期);第21-22页 * |
| 南京中医药大学编著.《芋头》.《中药大辞典》.上海科学技术出版社,2006,第1153-1154页. * |
| 尚清秀等.《肝肿大》.《社区医学杂志》.2007,第5卷(第24期),第21-22页. |
| 战志华等.《中医治疗水肿药物配伍规律的研究》.《承德医学院学报》.2005,第22卷(第1期),第34-38页. |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102526509A (en) | 2012-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101933991B (en) | Analgesic and anti-inflammatory medicament and preparation method thereof | |
| CN103386022B (en) | Chinese medicine composition for treating tuberculous pleurisy | |
| CN114306206B (en) | External traditional Chinese medicine composition for treating thyroid nodule and preparation method and application of external traditional Chinese medicine gel plaster | |
| CN103830632A (en) | Chinese traditional medicine preparation for radically treating psoriasis and multiple skin diseases and preparation method and application thereof | |
| CN103211933B (en) | Chinese medicament for treating hyperostosis | |
| CN105381132A (en) | Drug for treating thyroid nodule | |
| CN102091268A (en) | Medicament for treating allergic rhinitis and preparation method thereof | |
| CN102526509B (en) | Medicine for treating hepatomegaly | |
| CN103751547B (en) | Chinese medicine composition of a kind of blood fat reducing and preparation method thereof | |
| CN103961544A (en) | Medicine for treating breast diseases | |
| CN104436145A (en) | Pharmaceutical composition for preventing and/or treating allergic rhinitis and allergic asthma | |
| CN104435567A (en) | Traditional Chinese medicinal composition containing gynostemma pentaphyllum for treating gout | |
| CN104337989A (en) | Traditional Chinese medicine composition containing centipeda minima and frankincense for treating gout | |
| CN115282229A (en) | Traditional Chinese medicine composition for treating coronary heart disease with syndrome of qi deficiency and blood stasis and preparation method thereof | |
| CN104147270A (en) | Traditional Chinese medicine for treating acute hepatitis | |
| WO2016127771A1 (en) | Application of 20(r)-ginsenoside rg3 in preparing drug or healthcare product for alleviating or/and treating rheumatoid disease and drug containing 20(r)-ginsenoside rg3 | |
| CN101732469B (en) | Application of Chinese medicinal composition in preparation of medicament for treating aphonia | |
| CN102225155B (en) | Medicament composition for treating pulmonary fibrosis | |
| CN103948899A (en) | Traditional Tibetan medicine for treating atrophic gastritis | |
| CN101695534B (en) | Chinese patent medicament for treating mammary gland disease | |
| CN110841007B (en) | Traditional Chinese medicine composition for treating cerebral apoplexy sequela and application thereof | |
| CN101693058B (en) | Medicament for preventing and treating cold and inflammation infection | |
| CN106902330B (en) | Traditional Chinese medicine preparation for treating rheumatic arthritis and rheumatalgia and preparation method and application thereof | |
| CN106619870A (en) | Composition for treating digestive system neoplasms, and preparation method of composition | |
| CN109172756A (en) | A kind of Chinese medicine composition for treating hepatopathy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131204 Termination date: 20150131 |
|
| EXPY | Termination of patent right or utility model |